Case Report: Trousseau syndrome presenting as multifocal cerebral infarctions in advanced gastric signet-ring cell carcinoma: tumor burden–driven hypercoagulability - Scorecard - MDSpire

Case Report: Trousseau syndrome presenting as multifocal cerebral infarctions in advanced gastric signet-ring cell carcinoma: tumor burden–driven hypercoagulability

  • By

  • Haocheng Zhao

  • Shanshan Lin

  • Wenye Huang

  • July 15, 2026

Share

Clinical Scorecard: Case Study: Trousseau Syndrome Manifesting as Multiple Cerebral Infarcts in Advanced Signet-Ring Cell Carcinoma of the Stomach: Hypercoagulability Induced by Tumor Load

At a Glance

CategoryDetail
ConditionMalignancy-associated hypercoagulability
Key MechanismsTumor-derived tissue factor expression, cancer procoagulant activity, mucin-mediated platelet aggregation, systemic inflammatory responses
Target PopulationPatients with advanced gastric signet-ring cell carcinoma
Care SettingOncology and neurology departments

Key Highlights

  • Advanced gastric signet-ring cell carcinoma can lead to multiple cerebral infarcts.
  • D-dimer levels are markedly elevated in malignancy-associated hypercoagulability.
  • Anticoagulation may not prevent thrombotic events in advanced cancer.
  • Effective tumor-directed therapy may reduce hypercoagulability.
  • Multidisciplinary intervention is essential for optimal management.

Guideline-Based Recommendations

Diagnosis

  • Consider malignancy-associated hypercoagulability in patients with advanced cancer presenting with thromboembolic events.

Management

  • Initiate anticoagulation in patients with malignancy-associated thromboembolic complications.

Monitoring & Follow-up

  • Regularly assess D-dimer levels to evaluate coagulation status.

Risks

  • Patients with advanced malignancies are at increased risk for arterial thrombotic events despite anticoagulation.

Patient & Prescribing Data

76-year-old male with advanced gastric signet-ring cell carcinoma

Anticoagulation with enoxaparin sodium was initiated after stabilization of gastrointestinal bleeding.

Clinical Best Practices

  • Monitor D-dimer levels in patients with advanced malignancies.
  • Consider systemic chemotherapy as part of the management strategy for hypercoagulability.
  • Implement early multidisciplinary interventions for neurological and oncologic management.

Related Resources & Content

Original Source(s)

Related Content